ArticleExperimental hematology2022

Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment.

Ariella Tvito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.